Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets
- PMID: 7236992
- PMCID: PMC2071680
- DOI: 10.1111/j.1476-5381.1981.tb10436.x
Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets
Abstract
1 The effects of an adenosine diphosphate (ADP) analogue, adenosine 5'-O-(2-thiodiphosphate) (ADP-beta-S), in which a terminal phosphate oxygen has been replaced by sulphur, were studied on human platelets. 2 ADP-beta-S induced platelet aggregation and inhibited prostaglandin E1 (PGE1)-stimulated adenylate cyclase but in both cases was less potent than ADP and did not achieve the same maximal effects. 3 Both actions of ADP could be inhibited by the simultaneous addition of ADP-beta-S (50 microM). 4 Aggregation induced by 11 alpha, 9 alpha-epoxymethano prostaglandin H2 (a stable endoperoxide analogue) was not inhibited by simultaneous addition of ADP-beta-S (50 microM). 5 The behaviour of ADP-beta-S towards human platelets was consistent with it being a partial agonist.
Similar articles
-
Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.Br J Pharmacol. 1981 Jun;73(2):409-12. doi: 10.1111/j.1476-5381.1981.tb10437.x. Br J Pharmacol. 1981. PMID: 7236993 Free PMC article.
-
Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.Br J Pharmacol. 1993 Mar;108(3):728-33. doi: 10.1111/j.1476-5381.1993.tb12869.x. Br J Pharmacol. 1993. PMID: 8467360 Free PMC article.
-
Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).Br J Pharmacol. 1982 Feb;75(2):257-9. doi: 10.1111/j.1476-5381.1982.tb08781.x. Br J Pharmacol. 1982. PMID: 6892270 Free PMC article.
-
Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.Br J Pharmacol. 1999 Jul;127(6):1359-66. doi: 10.1038/sj.bjp.0702690. Br J Pharmacol. 1999. PMID: 10455285 Free PMC article.
-
ADP receptors in platelets.Ann N Y Acad Sci. 1990;603:198-209; discussion 209-10. doi: 10.1111/j.1749-6632.1990.tb37673.x. Ann N Y Acad Sci. 1990. PMID: 2291522 Review. No abstract available.
Cited by
-
Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.Br J Pharmacol. 1981 Jun;73(2):409-12. doi: 10.1111/j.1476-5381.1981.tb10437.x. Br J Pharmacol. 1981. PMID: 7236993 Free PMC article.
-
Platelet beta-adrenoceptors.Br J Pharmacol. 1983 Jul;79(3):681-91. doi: 10.1111/j.1476-5381.1983.tb10005.x. Br J Pharmacol. 1983. PMID: 6140045 Free PMC article.
-
Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.Br J Pharmacol. 1993 Mar;108(3):728-33. doi: 10.1111/j.1476-5381.1993.tb12869.x. Br J Pharmacol. 1993. PMID: 8467360 Free PMC article.
-
Strong G-Protein-Mediated Inhibition of Sodium Channels.Cell Rep. 2018 May 29;23(9):2770-2781. doi: 10.1016/j.celrep.2018.04.109. Cell Rep. 2018. PMID: 29847805 Free PMC article.
-
Nomenclature and classification of purinoceptors.Pharmacol Rev. 1994 Jun;46(2):143-56. Pharmacol Rev. 1994. PMID: 7938164 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources